FY total loss was CHF 18.6M, primarily driven by R&D expenditures of CHF 12.7M.Spexis’ cash position as of December 31, 2022 was CHF 1.8M.
Read Full Story at source (may require registration)
- What is Meant by “Discovery” in Sales? A Strategy for Building Trust and Driving Conversions - March 12, 2025
- How to Sell a Small Business: A Starter Guide for Business Owners - February 3, 2025
- European Shares Drift Lower Amid France’s Debt Woes - November 27, 2024